SRx Health Solutions, Inc. (SRXH) Form 10-Q — May 14, 2026
SRx Health Solutions reported a net loss of $6.4 million for Q1 2026, driven by $3.4 million in revenue from its continuing pet food operations (Halo) and significant non-cash charges related to digital assets and debt. The company has effectively spun off its failing Canadian healthcare business into CCAA bankruptcy proceedings, which are now classified as discontinued operations with no current-period impact on the income statement. The company aggressively raised capital during the quarter, issuing approximately 368 million shares through ELOC drawdowns, preferred stock offerings, and warrant exercises, generating roughly $68 million in gross proceeds.
Key figures
- Revenue
- 3439000
- Total Debt
- 22616000
- Cash Position
- 20543000
- Shares Outstanding
- 415964972
- Series BProceeds
- 4500000
- Digital Assets Value
- 8333000
- Digital Assets Cost Basis
- 8141000
- Loss From Discontinued Ops
- 0
- Eloc Commitment Note Principal
- 20000000
- Series BPreferred Shares Issued
- 5660
- Eloc Commitment Note Carrying Value
- 22616000
Price after filing
Close on the filing date to close N calendar days later (from $0.14). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.